Sector revisions Charles River Laboratories International, Inc. Deutsche Boerse AG
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 204.10 EUR | -0.34% |
|
+1.64% | +18.77% |
| 07-29 | Align Technology to add directors, launch review after deal with Elliott | RE |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 23 | |||||||
| 21 | |||||||
| 18 | |||||||
| 27 | |||||||
| 24 | |||||||
| 12 | |||||||
| - | 18 | ||||||
| 14 | |||||||
| 16 | |||||||
| 11 | |||||||
| 6 | |||||||
| 12 | |||||||
| 11 | |||||||
| 13 | |||||||
| 21 | |||||||
| 19 | |||||||
| 14 | |||||||
| 22 | |||||||
| - | - | ||||||
| Average | 17 | |||||||
| Weighted average by Cap. | 19 |
Select your edition
All financial news and data tailored to specific country editions
